BT-700 CART(Base Therapeutics (Shanghai) Co Ltd)

N/A

Report date: 2025/10/28 10:56:07

Base Information

Drug NameBT-700 CART(Base Therapeutics (Shanghai) Co Ltd)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Gene therapy > Gene editing

Mechanisms of ActionT lymphocyte replacements

TargetsUpdating

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesBase Therapeutics (Shanghai) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBase Therapeutics (Shanghai) Co Ltd

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A